miR-144-3p was significantly downregulated in hepatocellular carcinoma, glioblastoma, multiple myeloma and pancreatic cancer and inhibited proliferation, migration and tumour metastasis by targeting SGK3 (Wu et al., 2017), FZD7 (Cheng et al., 2017), c-Met (Zhao et al., 2017) and FOSB (Liu et al., 2018). This evidence concerns the gene MET and neoplasm.